Results 161 to 170 of about 35,844 (248)

Increased breast tissue receptor activator of nuclear factor- κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women [PDF]

, 2017
Appleton, Catherine M, Colditz, Graham A, Dang, Ha X, Hagemann, Ian S, Luo, Jingqin, Maher, Christopher A, Toriola, Adetunji T   +6 more
core   +2 more sources

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid [PDF]

, 2014
Roger von Moos, Jean-Jacques Body, Blair Egerdie, Alison Stopeck, Janet E. Brown, Danail Damyanov, Lesley Fallowfield, Gavin Marx, Charles S. Cleeland, Donald L. Patrick, Felipe Palazzo, Yi Qian, Ada Braun, Karen Chung   +13 more
openalex   +1 more source

Denosumab: A Useful Addition to the Armamentarium for the Management of Male Osteoporosis [PDF]

Jijith Krishnan, Sham Santhanam, Bhuwan Singh, Salim Patel, Divya Bhojwani, Sameer Muchhala   +5 more
openalex   +1 more source

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy [PDF]

, 2008
Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, Cristina Alvarado, Philippe Solal‐Céligny, J.J. Body, Richard de Boer, Rossana Berardi, Pere Gascón, Katia Tonkin, Robert E. Coleman, Alexander Paterson, Guozhi Gao, A. Kinsey, Mark Peterson, Susie Jun   +15 more
openalex   +1 more source

Denosumab Versus Bisphosphonates in Glucocorticoid-Induced Osteoporosis: A Systematic Review. [PDF]

Cureus
Ahmed AE, Alzaylaee WA, Suhluli AS, Essa SA, Bahkali LM, Hakami AM, Alshamrani RA, Alharbi FR, Alhazmi RH, Khurayzi TH, Almihbash AK.   +10 more
europepmc   +1 more source

Romosozumab after rebound vertebral fractures induced by denosumab discontinuation: a case series. [PDF]

JBMR Plus
Sarli M, Farias V, Abdala R, Armanelli E, Bocci C, Jerkovich F, Zanchetta MB.   +6 more
europepmc   +1 more source

Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report [PDF]

, 2015
Allen R. Hendricks, Aylin R. Rodan, Javier A. Neyra, Natalia A. Rocha, Omkar U. Vaidya, Rhea Bhargava   +5 more
core   +1 more source

Case presentation of a CRSwNP patient with severe cortisone-induced osteoporosis and dual biologics therapy with denosumab and dupilumab

, 2022
Valeria Valova, Ulrike Förster‐Ruhrmann, Heidi Olze   +2 more
openalex   +1 more source

Risk factors for skeletal-related events in patients with stage IV lung adenocarcinoma and bone metastases receiving denosumab: a retrospective cohort analysis. [PDF]

Support Care Cancer
Zhang H, Wen D, Liao Z, Tan X, Wang H, Xiang J, Yan B.   +6 more
europepmc   +1 more source

Denosumab usage is associated with better overall survival of patients with lung cancer and bone metastases: a retrospective cohort study. [PDF]

BMJ Open Respir Res
Yu CC, Lee HS, Wu JT, Huang CC, Chen JY.
europepmc   +1 more source